Ashley Zehnder, Fauna Bio CEO
March 14, 2025 05:39 AM EDTUpdated 07:03 AM
Financing
Startups

Lil­ly-part­nered Fau­na Bio plans $40M Se­ries A to get in­to heart fail­ure

Kyle LaHucik

Senior Reporter

MI­A­MI — Fau­na Bio, a biotech that mines da­ta on dis­ease re­sis­tance from squir­rels and oth­er an­i­mals to cre­ate new drugs, is look­ing at rais­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er ter­mi­nates an ear­ly-stage STING ag­o­nist tri­al

Moon­Lake's CEO on its loom­ing mid-year piv­otal read­out in skin dis­ease

Mer­ck di­ver­si­ty leader to re­tire this sum­mer; Geron seeks com­mer­cial chops for next CEO

In­side NYC’s wait­list-on­ly health tech club, where young pro­fes­sion­als find both friends and jobs

Trump blog: Fed­er­al agen­cies must give jobs back to fired pro­ba­tion­ary work­ers, judge rules

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times